Akiei Hamano

Title: Akiei Hamano: Innovator in Blood Coagulation Detection

Introduction

Akiei Hamano is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of blood coagulation processes. His innovative work has led to advancements that enhance the sensitivity and speed of coagulation detection.

Latest Patents

Hamano holds a patent for a monoclonal antibody specific to anti-human fibrin monomer, along with the process for producing it, hybridomas, and an immunoassay method. This patent provides a monoclonal antibody that enables the detection of native fibrin monomer, which is produced during the initial stages of blood coagulation, as well as soluble fibrin. The immunoassay developed using this antibody allows for high sensitivity and rapid detection of the initial stage of blood coagulation. The method involves using a fibrinogen analog as an immune source, with cell fusion techniques to prepare a monoclonal antibody that is specifically reactive with the native fibrin monomer and soluble fibrin.

Career Highlights

Hamano is associated with Nissui Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in medical diagnostics. His work has not only contributed to the scientific community but has also had practical applications in clinical settings.

Collaborations

Some of his notable coworkers include Seiji Tanaka and Mamoru Umeda, who have collaborated with him on various projects related to blood coagulation and immunoassay methods.

Conclusion

Akiei Hamano's contributions to the field of blood coagulation detection through his innovative patent have paved the way for improved diagnostic methods. His work exemplifies the impact of scientific research on healthcare advancements.